NEW YORK, Dec. 12 (GenomeWeb News) - Applera has agreed to pay Genetic Technologies an undisclosed amount to settle their ongoing patent-infringement suit surrounding the firm's junk DNA gene-testing technologies, according to Genetic Technologies.
Registering provides access to this and other free content.
Already have an account?Login Now.
A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.
UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.
Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.
In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.